The adherence to hand hygiene practices among the adult Intensive Care Unit (ICU) professionals in this hospital has not improved substantially in the last years, regardless of the theoretical training sessions conducted. A study was made of the knowledge, attitudes, and practices of the ICU personnel in this field. Several small discussion groups with ICU staff organised by preventive medicine professionals were scheduled in March 2018. Semi-structured questions on hand hygiene and use of gloves were included. The points discussed were listed into strengths and weaknesses. Knowledge was then assessed using an anonymous questionnaire, after the sessions. Thirteen 60-minute sessions were carried out with 157 participants from all professional categories (82% from ICU, median=11 participants / session). The majority perceived hand hygiene as a priority issue of personal responsibility for patient safety. They identified factors that limit their ability to improve their adherence. Certain habits have more to do with personal preferences than with theoretical knowledge or technical indications. The discussion groups have helped to make a diagnosis of the situation that will be useful to strengthen those areas of improvement that have been identified. If we aim for a cultural change, and eliminate incorrect habits, it seems more useful to carry out adequate continuing education as part of the daily routine of professionals. The discussion groups have helped to make a diagnosis of the situation that will be useful to strengthen those areas of improvement that have been identified. If we aim for a cultural change, and eliminate incorrect habits, it seems more useful to carry out adequate continuing education as part of the daily routine of professionals. To analyse the impact of a management plan for the diabetes process on the level of control of HbA1c and the rate of hypoglycaemia. The Health Area had a catchment population of 446,603. An anti-diabetic drug prescription (29,705 patients) was used to select diabetic patients. The variables recorded were percentage of patients with HbA1c <8% and the hypoglycaemia rate before and after implementation of the quality program. The prevalence of diabetes was 11.8%, with 71.3% of them receiving some pharmacological treatment. In the year 2016, in the Integrated Health Area of Santiago de Compostela (Spain), 59.6% (95% CI 57.9% -61.2%) of the patients had an HbA1c of less than 8%. After the implementation of the quality program, there was an increase in the number of controlled patients, reaching 63.6% (IRQ 16.0%) in 2017, and 63.8% (95% CI 62.5% - 65.2%) in 2018. The annual rate of hypoglycaemia increased non-significantly from 2.8 (95% CI 2.22-3.35) in 2016, to 2.94 (95% CI 2.35-2.35) in 2017 (P=.083), and 3.0 (95% CI 2.44-3.56) in 2018 (P=.399). The implementation of the diabetes process management program enabled the level of control of HbA1c to be improved, as well as increase the percentage of patients who undergo regular check-ups, without increasing hypoglycaemia. The implementation of the diabetes process management program enabled the level of control of HbA1c to be improved, as well as increase the percentage of patients who undergo regular check-ups, without increasing hypoglycaemia.Patient Blood Management (PBM) programs have proven to be successful in reducing overuse and improving patient safety, clinical outcomes and efficiency. Despite its benefits, PBM is still scarcely used in real clinical practice with a high variability among hospitals in Spain. Recent guidelines from the European Union on how to implement PBM, as well as recommendations from experts in the field, suggest that further development in PBM implementation requires not only the participation of healthcare professionals but also the commitment and support of Health Authorities and senior hospital management. This article provides some thoughts on health care management and policy strategies to help implement PBM throughout the Spanish autonomous healthcare systems. The Washington Group Short Set (WGSS) is increasingly being included in surveys worldwide to improve the quality and comparability of disability data within and between nations. However, compared to commonly employed binary impairment measures, the WGSS appears to have a relatively high threshold for disability indication. Empirical evidence is required to quantify this potential difference and its impact. To determine the agreement between a binary disability question (BDQ) and the WGSS measure administered concurrently in a large representative survey of adults. Two WGSS indication scenarios were considered one using the recommended threshold to indicate disability (WGSS1); and another using a lower threshold (WGSS2). A cross-sectional agreement study nested within the 2018 Canterbury Wellbeing Survey of randomly selected adults aged ≥18 years resident in the greater Christchurch region. From 2807 valid observations, 493 (17.6%), 259 (9.1%), and 822 (28.7%) participants were identified as having a disability by the BDQ, WGSS1 and WGSS2 measures, respectively. While concordance was high between BDQ and WGSS1 measures (85.3%), agreement was only fair (κ=0.37) and discordance was significantly asymmetrical (p<0.001). https://www.selleckchem.com/products/Sunitinib-Malate-(Sutent).html Participants were more likely to be indicated as 'disabled' using the BDQ but not indicated using the WGSS1 than vice versa. Different WGSS thresholds produce widely varying disability estimates, and the recommended WGSS1 resulted in an importantly reduced disability prevalence compared to a binary impairment measure when administered concurrently. This has profound implications for inclusivity and policy for people living with disability. Different WGSS thresholds produce widely varying disability estimates, and the recommended WGSS1 resulted in an importantly reduced disability prevalence compared to a binary impairment measure when administered concurrently. This has profound implications for inclusivity and policy for people living with disability.The inexorable rise of antimicrobial resistance reinforces the need for alternative approaches to both treat and prevent urinary tract infections (UTIs). A potential approach is administration of D-mannose, an inert monosaccharide that is metabolised and excreted in urine and acts by inhibiting bacterial adhesion to the urothelium. We performed a systematic review to assess the effect of D-mannose in the prevention of recurrent UTIs. Of the eight studies reporting on D-mannose in this context, six were clinical and included 695 individuals. Three studies reported that time to UTI recurrence was longer with D-mannose. D-Mannose improved quality of life and significantly reduced recurrent UTIs in both catheter and non-catheter users. D-Mannose was effective in reducing the incidence of recurrent UTIs and prolonging UTI-free periods, which consequently increased quality of life. PATIENT SUMMARY D-Mannose is a sugar that seems to reduce the incidence of recurrent urinary tract infections and associated bothersome symptoms.